血管体靶向股-远端旁路术对慢性肢体威胁性缺血愈合率及结局的影响
本研究回顾性分析177例患者201个不愈合缺血伤口,比较直接血运重建(DR)与间接血运重建(IR)对伤口愈合、大截肢率和死亡率的影响。结果显示DR与IR在愈合率、保肢率和死亡率上无显著差异,但自体大隐静脉DR的12个月愈合率最高(90%),冻存同种异体移植物在IR后愈合率也较好(85%)。
要点
- DR与IR在伤口愈合率、大截肢率和死亡率上无显著差异。
- 自体大隐静脉DR的12个月愈合率最高(90%)。
- 冻存同种异体移植物在IR后12个月愈合率达85%。
核心结论
- 根据血管体概念定义进行的直接或间接血运重建在愈合率、保肢率和死亡率方面结果相似。
研究设计与样本
- 回顾性分析根特大学医院177例患者(61%男性,中位年龄69岁)的201个不愈合缺血伤口(Rutherford 5和6类),随访36个月。
主要发现
- DR组103条腿(51%),IR组98条腿(49%),两组合并症无差异。
- 平均伤口愈合时间为7个月。
- 大截肢率IR后为28.5%,DR后为17.3%(p = .071)。
- 死亡率DR组36.8%,IR组41.3%(p = .088)。
- 自体GSV的初级通畅率、初级辅助通畅率和次级通畅率分别为26、34和38个月,优于冻存GSV的12.5、18和24个月(p = .002, p = .003, p = .018)。
关键数值与推荐
- DR组12个月愈合率:自体大隐静脉为90%。
- IR组12个月愈合率:冻存同种异体移植物为85%。
临床怎么用
- 对于慢性肢体威胁性缺血患者,直接或间接血运重建均可采用,优先考虑自体大隐静脉以提高通畅率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: In the presence of long lesions, in patients with chronic limb threatening ischaemia, a femorodistal bypass is often the only option to avoid major amputation. This study investigated whether targeted bypass to the affected angiosome, according to the angiosome concept definition of direct (DR) and indirect revascularisation (IR), has an impact on wound healing, major amputation rate, and mortality. METHODS: A retrospective analysis was performed at Ghent University Hospital of 201 non-healing ischaemic wounds (Rutherford categories 5 and 6) requiring femorodistal bypass surgery in 177 patients (61% male, median age 69 years) with a follow up of 36 months. For every patient, the site of the ulcer, the type of bypass, and material were identified. Based on ulcer location and distal anastomosis, the legs were divided into DR and IR. Kaplan-Meier univariable analysis was used to estimate cumulative ulcer healing, leg salvage, survival, and patency. RESULTS: DR was performed in 103 legs (51%) and IR in 98 legs (49%), with no difference in comorbidity. The mean wound healing time was seven months. DR did not lead to a higher healing rate. The fastest healing rate was obtained when opting for a DR with an autologous greater saphenous vein (GSV; 90% at 12 months). Cryopreserved allografts also yielded good results, especially for wound healing after IR (85% at 12 months). Major amputation was performed in 28.5% after IR vs. 17.3% after DR (p = .071). There was no difference in mortality rate (36.8% [DR] vs. 41.3% [IR]) (p = .088). Autologous GSV had a longer primary patency, primary assisted patency, and secondary patency (26, 34, and 38 months, respectively) than cryopreserved GSV (12.5, 18, and 24 months, respectively) (p = .002, p = .003, and p = .018, respectively), with no difference between DR and IR. CONCLUSION: Direct or indirect revascularisation performed according to the angiosome concept definition yields similar results with regard to healing rates, limb salvage, and mortality.
引用
- Harth C, Randon C, Vermassen F, et al. Impact of Angiosome Targeted Femorodistal Bypass Surgery on Healing Rate and Outcome in Chronic Limb Threatening Ischaemia. Eur J Vasc Endovasc Surg. 2020. PMID: 32312663. doi:10.1016/j.ejvs.2020.03.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。